Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Human papillomavirus and cardiovascular disease among U.S. women in the National Health and Nutrition Examination Survey, 2003 to 2006.

Kuo HK, Fujise K.

J Am Coll Cardiol. 2011 Nov 1;58(19):2001-6. doi: 10.1016/j.jacc.2011.07.038.

2.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
3.

Sociodemographic factors associated with high-risk human papillomavirus infection.

Kahn JA, Lan D, Kahn RS.

Obstet Gynecol. 2007 Jul;110(1):87-95. Erratum in: Obstet Gynecol. 2007 Sep;110(3):713.

PMID:
17601901
4.

Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?

Dunne EF, Sternberg M, Markowitz LE, McQuillan G, Swan D, Patel S, Unger ER.

J Infect Dis. 2011 Aug 15;204(4):562-5. doi: 10.1093/infdis/jir342.

5.

Prevalence of HPV infection among females in the United States.

Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE.

JAMA. 2007 Feb 28;297(8):813-9.

PMID:
17327523
6.

Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women.

Petignat P, Hankins C, Walmsley S, Money D, Provencher D, Pourreaux K, Kornegay J, Rouah F, Coutlée F; Canadian Women's HIV Study Group.

Clin Infect Dis. 2005 Aug 15;41(4):527-34. Epub 2005 Jul 14.

7.
9.

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K; DIANAIDS Collaborative Study Group.

Int J STD AIDS. 2003 Jun;14(6):417-25.

PMID:
12816671
10.

Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.

Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL.

Obstet Gynecol. 1994 Sep;84(3):404-8.

PMID:
8058239
11.

Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

Gravitt PE, Lacey JV Jr, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):95-100.

12.

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A.

J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.

13.

Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory.

O'Keefe EJ, Gardner A, Currie MJ, Garland S, Tabrizi S, Bowden FJ.

Sex Health. 2006 May;3(2):91-4.

PMID:
16800394
14.

HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.

Langley CL, Benga-De E, Critchlow CW, Ndoye I, Mbengue-Ly MD, Kuypers J, Woto-Gaye G, Mboup S, Bergeron C, Holmes KK, Kiviat NB.

AIDS. 1996 Apr;10(4):413-7.

PMID:
8728046
15.

Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.

Spinillo A, Debiaggi M, Zara F, De Santolo A, Polatti F, Filice G.

Obstet Gynecol. 2001 Jun;97(6):999-1004.

PMID:
11384710
16.

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.

Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML, Wilczynski SP.

J Natl Cancer Inst. 1996 Oct 2;88(19):1361-8. Review.

17.

Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers.

Lee JW, Berkowitz Z, Saraiya M.

Obstet Gynecol. 2011 Jul;118(1):4-13. doi: 10.1097/AOG.0b013e3182210034.

PMID:
21691157
18.

A population-based study of vaginal human papillomavirus infection in hysterectomized women.

Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, Hutchinson ML, Rodriguez AC, Wacholder S, Sherman ME, Kendall H, Viscidi RP, Jeronimo J, Schussler JE, Burk RD.

J Infect Dis. 2004 Aug 1;190(3):458-67. Epub 2004 Jul 2.

19.

Detection of genital human papillomavirus and associated cytological abnormalities among college women.

Kotloff KL, Wasserman SS, Russ K, Shapiro S, Daniel R, Brown W, Frost A, Tabara SO, Shah K.

Sex Transm Dis. 1998 May;25(5):243-50.

PMID:
9587175
20.

CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.

Chatterjee K, Dandara C, Hoffman M, Williamson AL.

BMC Cancer. 2010 Jun 10;10:278. doi: 10.1186/1471-2407-10-278.

Items per page

Supplemental Content

Write to the Help Desk